Gut microbiota exploitation by CPX-351 in AML; optimizing anti-myeloma immunity for ASCT; which pediatric ITP patients will develop lupus?
This episode explores how CPX-351 affects gut microbiota in acute myeloid leukemia, how to enhance anti-myeloma immunity for autologous stem cell transplantation, and predicts which pediatric patients with ITP might develop lupus.